Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Update to Johnson & Johnson PFA platform gains FDA approval
The Varipulse PFA platform originally gained FDA approval in 2024. According to Johnson & Johnson MedTech, this update was put in place to help the technology provide better patient outcomes going forward.
FDA approves Bayer's finerenone to treat wide range of heart failure patients
Finerenone, sold by Bayer under the brand name Kerendia, is now approved in the United States for the treatment of HFmrEF and HFpEF. The drug has already been used for years to treat patients with chronic kidney disease and type 2 diabetes.
FDA details multiple Class I recalls for Edwards Lifesciences surgical devices
Edwards Lifesciences has recalled more than 61,000 medical devices due to the risk of a small piece of wire becoming exposed. No patient injuries have been reported at this time.
CMS proposes Medicare coverage for renal denervation
This proposal, if finalized, would dramatically increase patient access to renal denervation. Both Recor Medical and Medtronic have shared their excitement over the news.
ASE shares new recommendations for evaluating LV diastolic function, HFpEF
The new guidelines detail the use of echocardiography to evaluate patients for a variety of conditions.

ACC: Healthcare workers ‘need Congress to act now’ and deliver COVID-19 stimulus

American College of Cardiology President Athena Poppas, MD, penned the statement, emphasizing how important it is for Congress to work together and get things done.

CVS Health thriving despite COVID setback

After weathering rising costs in its health insurance business due to claims coming in from rescheduled procedures, CVS Health expects excellent 2020 earnings on the strength of its diversified business model.

Essential workers in therapy resilient against COVID

More than 70% of people who receive mental health therapy via an app are stressed by changes in their lives caused by the COVID-19 crisis.

Promising outcomes reported for transcatheter mitral valve-in-valve replacement

The overall procedural technical success rate, researchers reported, was 96.8%.

FDA approves emergency use of Impella heart pumps to provide unloading therapy for COVID-19 patients

This is the second EUA for Abiomed's Impella heart pumps during the COVID-19 pandemic.

American Heart Association, Bill Gates donate $3.3M to new research initiative

The project includes a new technology research center at Boston University and support for scientists around the world.

Cardiovascular research taking a hit during pandemic

As the COVID-19 pandemic continues, researchers have been forced to put important projects on hold—and it’s unclear when things will return to normal.

The saga continues: 3 White House experts say hydroxychloroquine ineffective as a COVID-19 treatment

In the last six days, multiple White House experts have all emphasized they don’t support the use of hydroxychloroquine as a treatment option for COVID-19.

Clinical

Update to Johnson & Johnson PFA platform gains FDA approval

FDA approves Bayer's finerenone to treat wide range of heart failure patients

FDA details multiple Class I recalls for Edwards Lifesciences surgical devices

CMS proposes Medicare coverage for renal denervation

ASE shares new recommendations for evaluating LV diastolic function, HFpEF